Managing IP Finds Bill Lee Among Top 10 Litigators in Life Sciences Patent Industry
Lee has tried more than 100 patent cases, both jury and jury waived, to judgment and argued more than 50 appeals before the Court of Appeals for the Federal Circuit and other courts of appeals. His recent life sciences clients include Abbott Laboratories, for whom he obtained a significant victory in the United States Court of Appeals for the Federal Circuit with the complete reversal of a $1.67 billion patent-infringement verdict; and Nycomed GmbH and Wyeth, on behalf of whom Lee achieved a jury verdict in the United States District Court for the District of New Jersey upholding the validity of a patent covering the active ingredient in the blockbuster gastric acid disorder treatment PROTONIX in the face of a challenge by companies that had launched generic versions of the drug before patent expiration.
The selection of Managing IP’s “Top 10” litigators is based off of the research conducted for the recently announced LMG Life Sciences 2012 directory, in which the firm was found to be “highly recommended” for general patent litigation and as “recommended” for Hatch-Waxman patent litigation.
For more information on Managing IP magazine, click here.